Published in Cancer Weekly, February 10th, 2009
"We found that 8-Cl-Ado exposure inhibited Topo II-catalytic activities in K562...
Want to see the full article?
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Cancer Weekly
Source: Cancer Weekly (2009-02-10)
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.